Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SD Nanosciences is a San Diego-based biotechnology company specializing in the development of advanced nanoparticle-based drug delivery systems. The company's core technology involves a proprietary "nanodisc" platform designed to encapsulate and deliver hydrophobic therapeutic agents, improving their solubility, stability, and targeted delivery. SD Nanosciences primarily focuses on immuno-oncology, utilizing its platform to deliver potent immune stimulants like Toll-like receptor agonists directly to the tumor microenvironment. By enhancing the pharmacokinetic profiles of challenging drug candidates, the company aims to develop more effective treatments for cancer and inflammatory disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SD Nanosciences.